National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

hTERT I540/R572Y/D988Y multipeptide vaccine
A peptide vaccine consisting of multiple epitopes derived from the human telomerase reverse transcriptase (hTERT), the catalytic subunit of human telomerase, with potential immunostimulating and antineoplastic activities. hTERT I540/R572Y/D988Y multipeptide vaccine contains strongly antigenic peptide epitopes I540 (9-mer), R572Y (9-mer) and D988Y (10-mer). Vaccination with this agent may elicit a cytotoxic T cell (CTL) response against telomerase-expressing tumor cells. Directly linked to tumorigenesis, telomerase is expressed in the majority of human cancer cells but is infrequently expressed in normal cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:Hsp90 inhibitor BIIB028, Hsp90 inhibitor SNX-5422 mesylate, Hsp90 inhibitor STA-9090, HspE7, HSV-TK-transduced donor lymphocytes
Next:hu14.18-IL2 fusion protein, huBC1-huIL12 fusion protein AS1409, HuC242-DM4, human anti-alpha-v integrin monoclonal antibody, human anti-TGF-beta monoclonal antibody GC1008

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov